February 27th, 2021
Support Me Howdy! The Dolphins Challenge Cancer event will take place on April 10, 2021. The DCC is a collective community movement to raise money in support of much needed Sarcoma cancer research. Consider…

February 14th, 2021
The registration is now open for the Chondrosarcoma Foundation’s Second International Virtual Dialogue. It is scheduled for Saturday, March 20, 2021 from 1:00pm – 2:30pm (EST/ New York time) on Zoom. Please register at…

February 7th, 2021
Webinar Series Global Cell Therapy Virtual Symposium The journey from discovery to therapy begins with a single cell The path from research to effective cancer immune cell therapies requires innovative approaches to match the challenges we face….

January 30th, 2021
One week from today is Chondrosarcoma Awareness Day. Thank you for going on our web site and signing on to support our petition for Chondrosarcoma Research and Clinical Trials. The Chondrosarcoma Foundation is initiating an international public…

Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment of Soft Tissue Sarcoma (STS) Immunicum AB (publ; IMMU.ST) announced today that it has received Orphan Drug Designation (ODD) from the U.S. Food and Drug…

Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma This phase II trial studies the effect of belinostat and SGI-110 (guadecitabine) combination therapy in…

January 27th, 2021
We are 11 days from Chondrosarcoma Awareness Day. If you have not already done this, we are counting on you to do the following: 1. Get the Word Out. Join us in our efforts to educate the public about Chondrosarcoma, a rare bone and soft tissue…

January 24th, 2021
The Chondrosarcoma Awareness Day is getting the attention from many media outlets across the globe. We are doing our best to raise awareness and support for Chondrosarcoma research and clinical trials. Please check out the links…

January 21st, 2021
The Bowie, MD-based Chondrosarcoma CS Foundation, Inc. is launching an international public campaign to raise awareness and support for Chondrosarcoma research and clinical trials. They are proclaiming February 6, 2021, as Chondrosarcoma Awareness…

January 18th, 2021
Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients Registration-enabling study expected to begin dosing in the second or third quarter of this year SAN DIEGO,…